Abstract
Feiba Global Outcome Study (FEIBA-GO): Long-Term Real World Data on Apcc (FeibaR) in Patients with Inhibitors. First Demographic Data
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1182/blood.v128.22.5038.5038
Copy DOIJournal: Blood | Publication Date: Dec 2, 2016 |
Feiba Global Outcome Study (FEIBA-GO): Long-Term Real World Data on Apcc (FeibaR) in Patients with Inhibitors. First Demographic Data
Join us for a 30 min session where you can share your feedback and ask us any queries you have